Accent Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-508
Closed -$9.33K 334
2026
Q1
$9.33K Buy
508
+168
+49% +$688 ﹤0.01% 206
2025
Q4
$7.36K Buy
340
+190
+127% +$1.63K ﹤0.01% 235
2025
Q3
$4.06K Hold
150
﹤0.01% 341
2025
Q2
$3.64K Buy
+150
New +$2.34K ﹤0.01% 356

Other funds holding OM

Accent Capital Management's OM Position: Q2 2026 in Review

Accent Capital Management sold out of Outset Medical (OM) in Q2 2026, closing a stake of 508 shares — an estimated $9.33K sold.

Accent Capital Management first reported a position in OM in Q2 2025 and held it in 4 quarters. The position peaked at $9.33K in Q1 2026. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Accent Capital Management reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Accent Capital Management sold 508 Outset Medical shares in Q2 2026, an estimated $9.33K.
  • Accent Capital Management first reported a position in Outset Medical in Q2 2025 and held it in 4 quarters.
  • Accent Capital Management's Outset Medical position peaked at $9.33K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.